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a b s t r a c t
Objectives: Occlusal trauma is an important factor to influence alveolar bone remodelling,
the effect of which includes many cytokines and signalling pathways. However, the exact
mechanism of the traumatic stimulus for alveolar remodelling is still unclear. The purpose
of the present study was to investigate the early responses of alveolar osteocytes to occlusal
trauma through genome-wide microarray.
Methods: The occlusal surface of the upper left first molar of rat was raised by placing a
stainless steel wire to induce occlusal trauma in the lower left first molar. After 24 h, we took
out the alveolar bone tissue of the first molars at the both sides of rats’ lower jaws under
anaesthesia. The different gene expressions were showed by genome-wide microarray,
which comprises about 27,000 genes and the results were examined by quantitative RT-PCR.
Result: Of the approximately 27,000 genes, the expression of 586 genes was strongly
changed. These findings clearly demonstrated that in the early response of the alveolar
bone to occlusal trauma, the expression of osteoblast, collagens, bone mineralization, bone
remodelling and WNT, TGF-b pathway related cytokines decreased, and osteoclast-specific
cytokines have no significant changes in expression.
Conclusion: These results suggested that at early phase of the occlusal trauma, osteogenesis
in rat’s alveolar bone was inhibited, and osteoclastogenesis was not significant.
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Mechanical force is an important factor that affects skeletal
homeostasis.1,2 The balance between osteoblastic bone
formation and osteoclastic bone resorption plays an impor-
tant role to maintain this homeostasis. Mechanical loading
stimulates an anabolic response in osteoblasts by acting
together with cytokines, growth factors and hormones.3–5 The
term for the underlying mechanism for this response is called
mechanotransduction,1,6 which comprises the detection of
the physical stimulus by the cell, the transformation of this* Corresponding author at: No.44-1 Weihuaxi Road, Jinan, Shandong 2
E-mail address: whitedove69@163.com (H. Sun).
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Open access under CC BY-NC-ND license.transduction into the nucleolus, where gene transcription is
modified. In the signal transmission process, osteocytes fulfil
an important function by releasing molecular factors, during
the early response on mechanical loading.7,8 These paracrine
factors activate osteoblasts on the surface of the bone, which
increase their proliferation and matrix synthesis. The cellular
response depends on the type, magnitude, and duration of the
mechanical strain.2,9,10
Occlusal force plays an important role in the homeostasis
of alveolar bone. The forces produced by normal occlusion
have an inhibitory effect on unopposed eruption and50012, China. Tel.: +86 13969181267.
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force can stimulate alveolar bone tissue and prevent alveolar
bone resorption, whilst traumatic occlusion can cause
alveolar bone resorptive atrophy. Traumatic occlusal force
causes specific genes expression change of osteoblasts and
osteoclasts, so as to cause bone resorption.14–21 Both of these
phenomena are superimposed over the normal bone turnover
process mediated by osteoblasts and osteoclasts.22 Research-
ers find that stress can cause the tissue fluid in bone matrix
flows, and induce information transmits between osteoclasts
and between osteoclasts and osteoblasts.23 Also, the exact
molecular mechanisms associated with this metabolism
response of alveolar bone on traumatic occlusion are still
unclear.
Research on the influence of occlusal trauma to rat’s
alveolar bone resorption signal pathways are rather few,
and the researches are just focus on one or a few key factors
in bone metabolic signal pathway.21,24 To understand in
more detail the role of traumatic occlusal force on alveolar
resorption, we used a model of traumatic hyperocclusion to
investigate the signal transduction changes and molecular
mechanisms. This experiment adopted the samples of the
alveolar bones at left and right lower jaw with and without
occlusal trauma respectively in the same rat’s body, and
eliminated the influences of other interference factors,
such as animal individual difference, to experiment results
as possible, which is in favour of the research on the
influences of occlusal trauma factor to alveolar bone
resorption. In addition, genome-wide microarray technology
was used to obtain a high-throughput of information on
alveolar bone resorption by traumatic occlusion force.
The strategy of this study is to perform a large-scale analysis
of gene expression in order to highlight possible regulation
pathways differentiated by traumatic occlusion in early
phase.
2. Materials and methods
2.1. Animal
The experiment was conducted with male SD rats (250  10 g)
from Laboratory Animal Centre of Shandong University (Jinan,
China). The animals were housed under conditions of
controlled temperature (23  2 8C) and humidity (60%) with
natural light. The experimental protocol was developed
according to the institution’s guideline for the care and use
of laboratory animals.
2.2. Establishment of rat’s occlusal trauma model
Anaesthesia was accomplished using chloral hydrate 40 ml/kg
(Qilu Hospital in Shandong University, Jinan, China). In order
to create a hyperocclusive state 1 mm MEAW was bonded on
the occlusion surface of the first molar at left upper jaw by
means of super-bond composite resin accumulation to form
the occlusal trauma model of the first molar at the same side of
lower jaw, which was taken as the experiment group, whilst
the lower jaw of the opposite side was taken as the
contradistinctive group.2.3. Acquisition of alveolar bone samples
After the treatment for 24 h, the animal was sacrificed by the
intraperitoneal injection of chloral hydrate 40 ml/kg (Qilu
Hospital), and then the first molars at the both sides of the
lower jaw were extracted. Lower jaw bone tissues in the region
of the extracted teeth were ablated, isolated from the
mandibles, placed in liquid nitrogen for immediate freezing,
and stored in the 70 8C freezer.
2.4. Extraction of total RNA
All the glassware and mortars were baked at 200 8C for 4 h to
inactivate RNA enzyme. The frozen alveolar bone was ground
rapidly in liquid nitrogen. Trizol Reagent kit (Gibco BRL
Company, USA) was used to extract total RNA of the tissues.
Then used gel electrophoresis to test whether the extracted
RNA was degradted, and measured the OD value (A260/A280)
with spectrophotometer(Agilent, Shanghai, China) to test the
content and purity of RNA. For gel electrophoresis the 28S and
18S ribosomal RNA bands should be fairly sharp, intense
bands. The intensity of the upper band should be about twice
that of the lower band, and for spectrophotometer, the O.D.
A260/A280 ratio should be more than 1.8. The extracted RNA
was stored at 70 8C.
2.5. Genome-wide oligonucleotide microarrays analysis
Microarray analysis was performed by rat genome-wide
oligonucleotide microarrays in CapitalBio Corp. (Beijing,
China).25 Briefly, a Rattus norvegicus genome oligonucleotide
set (version 3.0),which was consisted of 269,625 amino
acidmodified 70-mer probes representing 22,012 genes and
27,044 gene transcripts, was purchased (Operon, Huntsville,
AL) and printed on silanized glass slides using a SmartAr-
rayTM microarrayer (CapitalBio). Five micrograms DNase-
treated total RNA was prepared and fluorescent dye (Cy5 and
Cy3-dCTP)-labelled cDNA, produced through Eberwine’s
linear RNA amplification method26 and subsequent enzy-
matic reaction, were then hybridized to an array. Finally,
arrays were scanned with a confocal LuxScanTM scanner
(CapitalBio), and extract the data of obtained images with
SpotData software (CapitalBio). A space and intensity-
dependent normalization based on a LOWESS programme
(except ‘program’ in computers) was employed.27 Genes with
the signal intensity (Cy3 or Cy5) > 800 were regarded as the
expressed ones. Using a reversal fluorescent strategy, two
hybridizations were performed for each test and contra-
distinctive samples. Those genes whose alteration tendency
kept consistent in both arrays and the mean expression ratios
averaged above 1.5-fold were selected as differentially
expressed genes.
2.6. Quantitative RT-PCR
To confirm the microarray results, three representative genes
were analysed by quantitative RT-PCR, according to the
methods modified by Guo et al.25 cDNA was prepared from
2 mg DNase-treated total RNA from each test or contra-
distinctive sample using the First Strand SuperScript II Kit
Table 1 – Sequences of primers used in quantitative real-time reverse transcription polymerase chain reaction.
Gene symbol Gene (full name) Forward primer (50 ! 30) Reverse primer (50 ! 30)
Actin Actin GTACCCAGGCATTGCTGACA CTCCTGCTTGCTGATCCACATC
Bglap Bone gamma-carboxyglutamate (gla)protein GTCCAAGCAGGAGGGCAGTA GTGGTCCGCTAGCTCGTCAC
Alpl Alkaline phosphatase 1 TGGTGGATTATGCTCACAACAA CCTCAGAACAGGGTGCGTAG
Wnt4 Wingless-type MMTV integration site 4 CCTGACCACTGGAAACCCTG GTACCCAGGCATTGCTGACA
a r c h i v e s o f o r a l b i o l o g y 5 7 ( 2 0 1 2 ) 7 3 7 – 7 4 3 739(Invitrogen). Quantitative RT-PCRs were performed by the
DNA Master SYBR Green I Kit and the LightCycler (Roche
Diagnostics, Mannheim, Germany)following the manufac-
turer’s protocols, and the results were analysed using
Lightcyler software version 3.5 (Roche Diagnostics). Single
PCR products were further verified by melting curve analysis
and 1.2% agarose gel electrophoresis. Noted that rat glyceral-
dehyde-3-phosphate dehydrogenase (Gapdh) was always
amplified in parallel with the representative genes. A
mathematical model reported by Pfaffl28 was employed to
analyse the relative expression ratio of these genes. The
relative expression ratio was determined by the formula
EðCP1-CP2Þgene =E
ðCP3-CP4Þ
Gapdh , in which E is quantitative RT-PCR efficien-
cy and CP is its crossing point. Primers used for quantitative
RT-PCR are listed in Table 1.
2.7. Additional microarray information
The description of this microarray study followed the
minimum information about a microarray experiment
(MIAME) guidelines.29 The detailed protocols for RNA isolation,
amplification, labelling, and hybridization can be provided by
the authors upon request.
3. Result
3.1. RNA Quantification and quality assurance by gel
electrophoresis and spectrophotometer
The result of gel electrophoresis showed the 28S and 18S
ribosomal RNA bands were fairly sharp, intense bands (Fig. 1).
The intensity of the upper band were about twice that of theFig. 1 – The result of gel electrophoresis.lower band, and for spectrophotometer, the O.D. A260/A280
ratio was2.0. All these showed that the RNA extracted from the
alveolar samples were not degraded.
3.2. Bone metabolism and related gene expression profiles
The transcript levels of the alveolar bone genes related to
bone metabolism in the hyperocclusion group compared
with the contradistinctive group are presented in Table 2. It
was evident that the magnitude of osteoblast-specific
genes were down-regulated in the early response of alveolar
bone to traumatic occlusion, but no changes were shown in
the osteoclast-specific genes (data not shown). The expres-
sion levels of the listed genes encoding collagens (type I, II,
III, V, XI, XXVII,) were diminished in the side of hyperocclu-
sion. The transcription levels of gene encoding MMP14 and
MMP2 were down-regulated in the hyperocclusion side.
Ossification, osteoblast differentiation, bone remodelling
and bone mineralization related genes were down-
regulated.
3.3. Signal transduction-related gene expression profiles
in hyperocclusion
Signal transduction pathway plays a key role in differentia-
tion, proliferation, and the function of bone cells. The changes
in the expression of the selected genes involved in signal
transduction are listed in Table 2. The expression of genes
related to TGF-b and Wnt signal pathways was found down-
regulated in the hyperocclusion side.
3.4. Confirmation of differential expression of selected
genes by Real-Time RT-PCR analysis
The microarray platform we used(Capitalbio) was validated by
the MicroArray Quality Control (MAQC) project initiated by the
US Food and Drug Administration (FDA).30 List of genes
expressed differently was generated by fold change, rather
than t-test P-value for gene selection, which is proposed to be
more reproducible.31 Moreover, gene list generated by fold-
change ranking with a nonstringent P-value cut-off showed
increased consistency in Gene Ontology terms and pathways,
and hence deduced the reliability of the biological impact.32 So
we used a 1.5-fold change in signal intensity as a cut-off line to
consider the differential expression of a gene as significant.
We validated our microarray findings by realtime RT-PCR
assays on the selected genes. And gene expression profiles of
some key factors obtained by microarray analysis and
quantitative RT-PCR were both downregulated, despite some
slight variations (Table 3). Collectively, results of the quanti-
tative PCR demonstrated the reliability of the microarray
analysis.
Table 2 – Changes in gene expression in the hyper- occlusion group compared with the contralateral group.





18406 Bone gamma-carboxyglutamate (gla) protein Bglap 0.2907
12703 Alkaline phosphatase 1 ALP1 0.6167
3613 Collagen type I, alpha1 Col1al 0.2285
Collagens
3613 Collagen type I, alpha1 Col1a1 0.2285
283 Collagen type XI, alpha2 Col11a2 0.3587
6926 Collagen type XXVII, alpha2 Col27a1 0.4338
3436 Collagen type V, alpha1 Col5a1 0.4674
2821 Collagen type III, alpha1 Col3a1 0.507
8133 Collagen type II, alpha1 Col2a1 0.514
21806 Collagen type XI, alpha1 Col11a1 0.5644
10566 Collagen type I, alpha2 Col1a2 0.5669
Matrix metalloproteinases
10064 Matrix metallopeptidase 14 MMP14 0.4929
15703 Matrix metallopeptidase 2 MMP2 0.6052
Ossification
3468 Amelogenin X chromosome Amelx 0.3687
21959 Odontogenic, ameloblast asssociated Odam 0.0193
18970 Insulin-like growth factor 2 Igf2 0.1872
10064 Matrix metallopeptidase 14 Mmp14 0.4929
3352 Ameloblastin Ambn 0.0464
3436 Collagen type V, alpha1 Col5a1 0.4674
23523 Exostoses (multiple) 1 Ext1 0.6112
3195 Amelotin Amtn 0.0367
12109 Secreted protein, acidic, cysteine-rich (osteonectin) Sparc 0.4189
Regulation of bone mineralization
18406 Bone gamma-carboxyglutamate (gla) protein Bglap 0.2907
14185 Osteomodulin Omd 0.6338
Osteoblast differentiation
18406 Bone gamma-carboxyglutamate (gla) protein Bglap 0.2907
Bone remodelling
12851 Ectonucleotide pyrophosphatase/phosphodiesterase1 Enpp1 0.5958
Wnt signalling pathway
4200 Wnt inhibitory factor 1 Wif1 0.5968
14014 Protein phosphatase 2, catalytic subunit, beta isoform Ppp2cb 0.5756
12043 Wingless-type MMTV integration site family, member 4 Wnt4 0.3832
2490 Glycogen synthase kinase 3 beta Gsk3b 0.6557
11706 Ras homolog gene family, member A Rhoa 0.6607
TGF-beta signalling pathway
2304 Transforming growth factor beta 2 Tgfb2 0.5232
14014 Protein phosphatase 2, catalytic subunit, beta isoform Ppp2cb 0.5756
13665 anti-Mullerian hormone receptor, type II Amhr2 0.1601
24584 inhibitor of DNA binding 3 ID3 0.5992
11706 Ras homolog gene family, member A Rhoa 0.6607
Table 3 – The result of differential expression of selected genes by Real-Time RT-PCR analysis.






contralateral ratio on chip)
18406 Bone gamma-carboxyglutamate (gla) protein Bglap 0.3084 0.2907
12703 Alkaline phosphatase 1 Alp1 0.5537 0.6167
12043 Wingless-type MMTV integration site family 4 Wnt4 0.2115 0.3832
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Super occlusion can cause rat’s occlusal trauma and alveolar
bone resorption.21 The present study provides gene transcript
profiles of the rat’s occlusal trauma for 24 h to help to reveal
further the molecular mechanisms underlying hyperocclusion
induced bone loss. Our emphasis was primarily on genes
engaged in bone metabolism, and the related signal transduc-
tion pathway mainly through Gene Ontology analysis and
Pathway analysis. Furthermore, the validity of our microarray
findings was confirmed by conducting real-time RT-PCR
assays on the selected genes. This experiment adopted the
method of bonding 1 mm steel wire on rat’s upper jaw molar to
establish the super-occlusion model, and the occlusion rising
distance for the rat sample could be more accurate and easier.
In addition, this experiment adopted the occlusal trauma side
of the same rat as the experiment group and the opposite side
as the contradistinctive group, which reduced the influences
of other factors, such as animal individual difference, to this
experiment, and was in favour of the research on the bone
resorption caused by occlusal trauma.
In this experiment, at 24 h of hyperocclusion, Osteoblast
specific genes, Bglap, ALP1 and Col1a1, significantly decreased
in expression. Bone gamma-carboxyglutamic acid-containing
protein (BGLAP, also known as Osteocalcin), is a noncolla-
genous protein found in bone and dentine.33,34 It is secreted
solely by osteoblasts and thought to play a role in the body’s
metabolic regulation and is pro-osteoblastic, or bone remo-
delling. It is also implicated in bone mineralization and
calcium ion homeostasis.35 And the expression of collagens,
ossification and bone remodelling related genes decreased
significantly. Amongst them, SPARC, also called osteonectin,
and sparc-related bone proteins, odontogenic, ameloblast
associated (ODAM), ameloblastin (AMBN) and amelotin
(AMTN) participate in early tissue mineralization of bone
remodelling.36,37 Matrix metallopeptidase 14 (MMP14) could
promoted the secretion of Matrix metallopeptidase2(MMP2),
both also involved in osteoblastic bone formation and/or
inhibits osteoclastic bone resorption.38
Wnt and TGF-b pathways are two of the significant
pathways participating in osteoblast differetiation and bone
formation.39–44 And the two pathway-related factors also
decreased significantly in this experiment. Previous experi-
ments proved that Wnt pathway is part of the normal
physiological reactions of mechanical loading to bone func-
tions, and is a component of osteoblastic bone cell early
responses to load-bearing.45 TGF-b plays stage-dependent
roles in osteoblast differentiation. TGF-b inhibits osteoblast
differentiation yet stimulates the proliferation of mesenchy-
mal progenitors, thereby expanding the population of cells
that will differentiate into osteoblasts.39 TGF-b activates
Smad3 binds Runx2 at the runx2 and osteocalcin promoters
to repress transcription of genes required for osteoblast
differentiation and bone matrix production.40,41 TGF-b also
regulates the expression of osteopontin, osteonectin, type I
collagen, and matrix metalloproteinases.42,43 Because these
proteins play roles in bone matrix organization and minerali-
zation,44 the regulation of their expression by TGF-b may
affect the material properties of bone matrix. Aiko Nakashimaand Zhongyu Liu proved that there is ‘‘cross-talk’’ between
wnt/b-Catenin pathway and TGF-b/BMP pathway and osteo-
blast differentiation can be influenced by the ‘‘cross-talk’’
between the two pathways.46,47 In this experiment, osteoblast
specific genes and Wnt and TGF-b pathway related factors
expression decreased significantly, in accordance with the
previous experiments. The changes of all these suggest that
that the influence of occlusal trauma to alveolar bone
resorption in early stage mainly lies in the inhibition on
osteoblast differentiation and activity.
In vitro studies attempting to define TGF-b effects on bone
resorption and on osteoclastogenesis have found variable
results, depending on the model system used. Thus, TGF-b has
been shown to induce apoptosis of mature osteoclasts48 and to
stimulate osteoprotegerin (OPG) production in bone marrow
stromal and osteoblastic cells.49,50 Since OPG binds to receptor
activator of NF-kB ligand (RANK-L), thus preventing it from
activating RANK on osteoclastic lineage cells.51 However,
other studies using systems containing both osteoclast
precursor cells and stromal/osteoblastic cells have found an
induction of osteoclastogenesis by TGF-b.52 These variable
results of TGF-b on osteoclast development could be due, in
part, to differing actions of TGF-b on osteoclast precursor cells
vs. the bone marrow stromal cells that support osteoclasto-
genesis.
Osteoclastogenesis is mainly controlled by two cytokines,
receptor activator of nuclear factor kappa B ligand (RANKL)
and macrophage colonystimulating factor (M-CSF).55 RANKL is
a member of the tumour necrosis factor super family that
activates osteoclast differentiation, stimulates osteoclast
activation and increases osteoclast survival.53–56 Walker CG
and Yoshinaga Y, found that RANKL contribute to the
stimulation of alveolar resorption in more than 24 h hyper-
occlusive state.21,24 While, in this experiment, the expressive
change of RANKL and M-CSF were not significant(data not
shown). It seems that in this experiment osteoclast differen-
tiation has not been included in the early reactions of alveolar
bone to occlusal trauma stimulation, only some osteoclast
inhibitory factors show expression decrease.
Our study is the first time microarray data has been
provided for an opportunity to gain a better understanding of
the basis for the impacts of hyperocclusion in rat on bone
resorption and to identify the related signal transduction
pathway. The results of our experiment show that the
magnitude of osteoblast-specific genes were down-regulated
in the early response of alveolar bone to traumatic occlusion,
whilst the change of the osteoclast-specific genes was not
shown, only some osteoclast inhibitory factors show expres-
sion decrease. Our experiment indicate that the influence of
occlusal trauma to alveolar bone in early stage mainly lies in
the decrease of anabolic effect of osteoblast and the effect of
bone resorption by osteoclast is not significant. However, it is
necessary to obtain further confirmation at the protein level
and with functional analysis.
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